Top

Virology Journal

Published in:

Open Access 01-12-2009 | Research

Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis

Authors: Yuki Furuse, Akira Suzuki, Taro Kamigaki, Hitoshi Oshitani

Published in: Virology Journal | Issue 1/2009

Abstract

Background

Influenza A virus infects not only humans, but also other species including avian and swine. If a novel influenza A subtype acquires the ability to spread between humans efficiently, it could cause the next pandemic. Therefore it is necessary to understand the evolutionary processes of influenza A viruses in various hosts in order to gain better knowledge about the emergence of pandemic virus. The virus has segmented RNA genome and 7th segment, M gene, encodes 2 proteins. M1 is a matrix protein and M2 is a membrane protein. The M gene may be involved in determining host tropism. Besides, novel vaccines targeting M1 or M2 protein to confer cross subtype protection have been under development. We conducted the present study to investigate the evolution of the M gene by analyzing its sequence in different species.

Results

Phylogenetic tree revealed host-specific lineages and evolution rates were different among species. Selective pressure on M2 was stronger than that on M1. Selective pressure on M1 for human influenza was stronger than that for avian influenza, as well as M2. Site-by-site analyses identified one site (amino acid position 219) in M1 as positively selected in human. Positions 115 and 121 in M1, at which consensus amino acids were different between human and avian, were under negative selection in both hosts. As to M2, 10 sites were under positive selection in human. Seven sites locate in extracellular domain. That might be due to host's immune pressure. One site (position 27) positively selected in transmembrane domain is known to be associated with drug resistance. And, two sites (positions 57 and 89) locate in cytoplasmic domain. The sites are involved in several functions.

Conclusion

The M gene of influenza A virus has evolved independently, under different selective pressure on M1 and M2 among different hosts. We found potentially important sites that may be related to host tropism and immune responses. These sites may be important for evolutional process in different hosts and host adaptation.

Available only for authorised users

Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y: Evolution and ecology of influenza A viruses. Microbiological Reviews 1992, 56: 152-179.PubMedCentralPubMed

Zhang W, Jiang Q, Chen Y: Evolution and variation of the H3 gene of influenza A virus and interaction among hosts. Intervirology 2007, 50: 287-295. 10.1159/000104788CrossRefPubMed

Bush RM, Fitch WM, Bender CA, Cox NJ: Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol. 1999,16(11):1457-1465.CrossRefPubMed

Fouchier RAM, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus ADME: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. Journal of Virology 2005, 79: 2814-2822. 10.1128/JVI.79.5.2814-2822.2005PubMedCentralCrossRefPubMed

Bean WJ, Schell M, Katz J, Kawaoka Y, Naeve C, Gorman O, Webster RG: Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. Journal of Virology 1992, 66: 1129-1138.PubMedCentralPubMed

Fitch WM, Leiter JM, Li XQ, Palese P: Positive Darwinian evolution in human influenza A viruses. Proceedings of the National Academy of Sciences of the United States of America 1991, 88: 4270-4274. 10.1073/pnas.88.10.4270PubMedCentralCrossRefPubMed

Shih AC-C, Hsiao T-C, Ho M-S, Li W-H: Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proceedings of the National Academy of Sciences of the United States of America 2007, 104: 6283-6288. 10.1073/pnas.0701396104PubMedCentralCrossRefPubMed

Ito T, Gorman OT, Kawaoka Y, Bean WJ, Webster RG: Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. Journal of Virology 1991, 65: 5491-5498.PubMedCentralPubMed

Lamb RA, Lai CJ, Choppin PW: Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proceedings of the National Academy of Sciences of the United States of America 1981, 78: 4170-4174. 10.1073/pnas.78.7.4170PubMedCentralCrossRefPubMed

10.

Nayak DP, Hui EK-W, Barman S: Assembly and budding of influenza virus. Virus Research 2004, 106: 147-165. 10.1016/j.virusres.2004.08.012CrossRefPubMed

11.

Schmitt AP, Lamb RA: Influenza virus assembly and budding at the viral budozone. Advances in Virus Research 2005, 64: 383-416. 10.1016/S0065-3527(05)64012-2CrossRefPubMed

12.

Cros JF, Palese P: Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Research 2003, 95: 3-12. 10.1016/S0168-1702(03)00159-XCrossRefPubMed

13.

Garcia-Robles I, Akarsu H, Muller CW, Ruigrok RWH, Baudin F: Interaction of influenza virus proteins with nucleosomes. Virology 2005, 332: 329-336. 10.1016/j.virol.2004.09.036CrossRefPubMed

14.

Naffakh N, Tomoiu A, Rameix-Welti M-A, Werf S: Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annual Review of Microbiology 2008, 62: 403-424. 10.1146/annurev.micro.62.081307.162746CrossRefPubMed

15.

Almond JW: A single gene determines the host range of influenza virus. Nature 1977, 270: 617-618. 10.1038/270617a0CrossRefPubMed

16.

Baudin F, Petit I, Weissenhorn W, Ruigrok RW: In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 2001, 281: 102-108. 10.1006/viro.2000.0804CrossRefPubMed

17.

Elster C, Larsen K, Gagnon J, Ruigrok RW, Baudin F: Influenza virus M1 protein binds to RNA through its nuclear localization signal. Journal of General Virology 1997, 78: 1589-1596.CrossRefPubMed

18.

Wakefield L, Brownlee GG: RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Research 1989, 17: 8569-8580. 10.1093/nar/17.21.8569PubMedCentralCrossRefPubMed

19.

Elster C, Fourest E, Baudin F, Larsen K, Cusack S, Ruigrok RW: A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction. Journal of General Virology 1994, 75: 37-42. 10.1099/0022-1317-75-1-37CrossRefPubMed

20.

Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ: Antiviral activity of influenza virus M1 zinc finger peptides. Journal of Virology 1996, 70: 8639-8644.PubMedCentralPubMed

21.

Ye Z, Liu T, Offringa DP, McInnis J, Levandowski RA: Association of influenza virus matrix protein with ribonucleoproteins. Journal of Virology 1999, 73: 7467-7473.PubMedCentralPubMed

22.

Gomez-Puertas P, Albo C, Perez-Pastrana E, Vivo A, Portela A: Influenza virus matrix protein is the major driving force in virus budding. Journal of Virology 2000, 74: 11538-11547. 10.1128/JVI.74.24.11538-11547.2000PubMedCentralCrossRefPubMed

23.

Latham T, Galarza JM: Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Journal of Virology 2001, 75: 6154-6165. 10.1128/JVI.75.13.6154-6165.2001PubMedCentralCrossRefPubMed

24.

Lamb RA, Zebedee SL, Richardson CD: Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 1985, 40: 627-633. 10.1016/0092-8674(85)90211-9CrossRefPubMed

25.

Holsinger LJ, Lamb RA: Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 1991, 183: 32-43. 10.1016/0042-6822(91)90115-RCrossRefPubMed

26.

Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K: Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunological Reviews 1997, 159: 95-103. 10.1111/j.1600-065X.1997.tb01009.xCrossRefPubMed

27.

Potter CW, Oxford JS: Determinants of immunity to influenza infection in man. British Medical Bulletin 1979, 35: 69-75.PubMed

28.

Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR: Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. Journal of Virology 1990, 64: 1375-1377.PubMedCentralPubMed

29.

Pinto LH, Holsinger LJ, Lamb RA: Influenza virus M2 protein has ion channel activity. Cell 1992, 69: 517-528. 10.1016/0092-8674(92)90452-ICrossRefPubMed

30.

Zebedee SL, Lamb RA: Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proceedings of the National Academy of Sciences of the United States of America 1989, 86: 1061-1065. 10.1073/pnas.86.3.1061PubMedCentralCrossRefPubMed

31.

Hughey PG, Roberts PC, Holsinger LJ, Zebedee SL, Lamb RA, Compans RW: Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology 1995, 212: 411-421. 10.1006/viro.1995.1498CrossRefPubMed

32.

Schroeder C, Heider H, Moncke-Buchner E, Lin T-I: The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. European Biophysics Journal 2005, 34: 52-66. 10.1007/s00249-004-0424-1CrossRefPubMed

33.

Chen BJ, Leser GP, Jackson D, Lamb RA: The influenza virus M2 protein cytoplasmic tail interacts with the m1 protein and influences virus assembly at the site of virus budding. Journal of Virology 2008, 82: 10059-10070. 10.1128/JVI.01184-08PubMedCentralCrossRefPubMed

34.

Castrucci MR, Kawaoka Y: Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein. Journal of Virology 1995, 69: 2725-2728.PubMedCentralPubMed

35.

McCown MF, Pekosz A: Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. Journal of Virology 2006, 80: 8178-8189. 10.1128/JVI.00627-06PubMedCentralCrossRefPubMed

36.

Ozawa M, Maeda J, Iwatsuki-Horimoto K, Watanabe S, Goto H, Horimoto T, Kawaoka Y: Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication. Journal of Virology 2009, 83: 3384-3388. 10.1128/JVI.02513-08PubMedCentralCrossRefPubMed

37.

Zharikova D, Mozdzanowska K, Feng J, Zhang M, Gerhard W: Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. Journal of Virology 2005, 79: 6644-6654. 10.1128/JVI.79.11.6644-6654.2005PubMedCentralCrossRefPubMed

38.

Liu W, Zou P, Chen Y-H: Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge. Immunology Letters 2004, 93: 131-136. 10.1016/j.imlet.2004.03.003CrossRefPubMed

39.

Zebedee SL, Lamb RA: Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. Journal of Virology 1988, 62: 2762-2772.PubMedCentralPubMed

40.

Lee LY, Ha DL, Simmons C, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, et al.: Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals[see comment]. Journal of Clinical Investigation 2008, 118: 3478-3490.PubMedCentralPubMed

41.

Zhirnov OP, Isaeva EI, Konakova TE, Thoidis G, Piskareva LM, Akopova II, Kartashov A, Altstein AD, Ilyinskii PO, Shneider AM: Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1. Influenza Other Respir Viruses 2007, 1: 71-79. 10.1111/j.1750-2659.2007.00010.xPubMedCentralCrossRefPubMed

42.

Fiers W, De Filette M, Birkett A, Neirynck S, Min Jou W: A "universal" human influenza A vaccine. Virus Research 2004, 103: 173-176. 10.1016/j.virusres.2004.02.030CrossRefPubMed

43.

Roose K, Fiers W, Saelens X: Pandemic preparedness: Toward a universal influenza vaccine. Drug News & Perspectives 2009, 22: 80-92.CrossRef

44.

Suzuki Y, Gojobori T: A method for detecting positive selection at single amino acid sites. Mol Biol Evol. 1999,16(10):1315-1328.CrossRefPubMed

45.

Sergei L, Kosakovsky Pond AFYP, Simon DW:Frost: Estimating selection pressures on alignments of coding sequences Analyses using HyPhy. 2007. [http://www.hyphy.org/pubs/hyphybook2007.pdf]

46.

Reid AH, Taubenberger JK, Fanning TG: Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nature Reviews Microbiology 2004, 2: 909-914. 10.1038/nrmicro1027CrossRefPubMed

47.

Dunham EJ, Dugan VG, Kaser EK, Perkins SE, Brown IH, Holmes EC, Taubenberger JK: Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. Journal of Virology 2009, 83: 5485-5494. 10.1128/JVI.02565-08PubMedCentralCrossRefPubMed

48.

Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, Oshitani H: Reversion of Influenza A (H3N2) from Amantadine-resistant to Amantadine-sensitive by Further Reassortment in Japan during the 2006–2007 Influenza Season. J Clin Microbiol 2009, 47: 841-844. 10.1128/JCM.01622-08PubMedCentralCrossRefPubMed

49.

Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, Smit M, Macken C, Hata M, Gog J, Miller MA, Holmes EC: The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Molecular Biology & Evolution 2007, 24: 1811-1820. 10.1093/molbev/msm103CrossRef

50.

Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, St George K, Grenfell BT, Salzberg SL, Fraser CM, Lipman DJ, Taubenberger JK: Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. Plos Biology 2005, 3: e300. 10.1371/journal.pbio.0030300PubMedCentralCrossRefPubMed

51.

Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, George KS, Griesemer SB, Ghedin E, Sengamalay NA, Spiro DJ, Volkov I, Grenfell BT, Lipman DJ, Taubenberger JK, Holmes EC: Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog. 2006,2(12):e138. 10.1371/journal.ppat.0020125PubMedCentralCrossRef

52.

Dugan VG, Chen R, Spiro DJ, Sengamalay N, Zaborsky J, Ghedin E, Nolting J, Swayne DE, Runstadler JA, Happ GM, et al.: The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathogens 2008, 4: e1000076. 10.1371/journal.ppat.1000076PubMedCentralCrossRefPubMed

53.

Reid AH, Fanning TG, Hultin JV, Taubenberger JK: Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene[see comment]. Proceedings of the National Academy of Sciences of the United States of America 1999, 96: 1651-1656. 10.1073/pnas.96.4.1651PubMedCentralCrossRefPubMed

54.

Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG: Initial genetic characterization of the 1918 "Spanish" influenza virus[see comment]. Science 1997, 275: 1793-1796. 10.1126/science.275.5307.1793CrossRefPubMed

55.

Scholtissek C, Stech J, Krauss S, Webster RG: Cooperation between the hemagglutinin of avian viruses and the matrix protein of human influenza A viruses. Journal of Virology 2002, 76: 1781-1786. 10.1128/JVI.76.4.1781-1786.2002PubMedCentralCrossRefPubMed

56.

Scholtissek C, Burger H, Kistner O, Shortridge KF: The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 1985, 147: 287-294. 10.1016/0042-6822(85)90131-XCrossRefPubMed

57.

Huang X, Liu T, Muller J, Levandowski RA, Ye Z: Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export. Virology 2001, 287: 405-416. 10.1006/viro.2001.1067CrossRefPubMed

58.

Takizawa N, Watanabe K, Nouno K, Kobayashi N, Nagata K: Association of functional influenza viral proteins and RNAs with nuclear chromatin and sub-chromatin structure. Microbes & Infection 2006, 8: 823-833. 10.1016/j.micinf.2005.10.005CrossRef

59.

Reinhardt J, Wolff T: The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Veterinary Microbiology 2000, 74: 87-100. 10.1016/S0378-1135(00)00169-3CrossRefPubMed

60.

Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S: Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nature Cell Biology 2001, 3: 301-305. 10.1038/35060098CrossRefPubMed

61.

Suzuki Y: Natural selection on the influenza virus genome. Molecular Biology & Evolution 2006, 23: 1902-1911. 10.1093/molbev/msl050CrossRef

62.

Bragstad K, Nielsen LP, Fomsgaard A: The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virology Journal 2008, 5: 40. 10.1186/1743-422X-5-40PubMedCentralCrossRefPubMed

63.

Gotch F, McMichael A, Smith G, Moss B: Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. Journal of Experimental Medicine 1987, 165: 408-416. 10.1084/jem.165.2.408CrossRefPubMed

64.

Jameson J, Cruz J, Ennis FA: Human cytotoxic T-lymphocyte repertoire to influenza A viruses. Journal of Virology 1998, 72: 8682-8689.PubMedCentralPubMed

65.

Ye ZP, Pal R, Fox JW, Wagner RR: Functional and antigenic domains of the matrix (M1) protein of influenza A virus. Journal of Virology 1987, 61: 239-246.PubMedCentralPubMed

66.

Bucher D, Popple S, Baer M, Mikhail A, Gong YF, Whitaker C, Paoletti E, Judd A: M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies. Journal of Virology 1989, 63: 3622-3633.PubMedCentralPubMed

67.

Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH: The molecular basis of the specific anti-influenza action of amantadine. EMBO Journal 1985, 4: 3021-3024.PubMedCentralPubMed

68.

Bright RA, Medina M-j, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI: Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern[see comment]. Lancet 2005, 366: 1175-1181. 10.1016/S0140-6736(05)67338-2CrossRefPubMed

69.

McCown MF, Pekosz A: The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. Journal of Virology 2005, 79: 3595-3605. 10.1128/JVI.79.6.3595-3605.2005PubMedCentralCrossRefPubMed

70.

Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D: The influenza virus resource at the National Center for Biotechnology Information. Journal of Virology 2008, 82: 596-601. 10.1128/JVI.02005-07PubMedCentralCrossRefPubMed

71.

Stamatakis A, Hoover P, Rougemont J: A rapid bootstrap algorithm for the RAxML Web servers. Systematic Biology 2008, 57: 758-771. 10.1080/10635150802429642CrossRefPubMed

72.

Felsenstein J: Evolutionary trees from DNA sequences: a maximum likelihood approach. Journal of Molecular Evolution 1981, 17: 368-376. 10.1007/BF01734359CrossRefPubMed

73.

Computing Large Phylogenies with Statistical Methods: Problems & Solutions[http://icwww.epfl.ch/~stamatak/index-Dateien/publications/BGRS2004.PDF]

74.

Tamura K, Nei M, Kumar S: Prospects for inferring very large phylogenies by using the neighbor-joining method. Proceedings of the National Academy of Sciences of the United States of America 2004, 101: 11030-11035. 10.1073/pnas.0404206101PubMedCentralCrossRefPubMed

75.

Anisimova M, Gascuel O: Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst Biol 2006, 55: 539-552. 10.1080/10635150600755453CrossRefPubMed

76.

Pond SLK, Frost SDW, Muse SV: HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21: 676-679. 10.1093/bioinformatics/bti079CrossRefPubMed

77.

Lanave C, Preparata G, Saccone C, Serio G: A new method for calculating evolutionary substitution rates. Journal of Molecular Evolution 1984, 20: 86-93. 10.1007/BF02101990CrossRefPubMed

78.

Campo DS, Dimitrova Z, Mitchell RJ, Lara J, Khudyakov Y: Coordinated evolution of the hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 2008, 105: 9685-9690. 10.1073/pnas.0801774105PubMedCentralCrossRefPubMed

79.

Kosakovsky Pond SL, Frost SD: Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005,22(5):1208-1222. 10.1093/molbev/msi105CrossRefPubMed

80.

Pond SLK, Frost SDW, Grossman Z, Gravenor MB, Richman DD, Brown AJL: Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Computational Biology 2006, 2: e62. 10.1371/journal.pcbi.0020062CrossRefPubMed

81.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ: The global circulation of seasonal influenza A (H3N2) viruses. Science 2008, 320: 340-346. 10.1126/science.1154137CrossRefPubMed

82.

Yang Z, Rannala B: Bayesian phylogenetic inference using DNA sequences: a Markov Chain Monte Carlo Method. Mol Biol Evol. 1997,14(7):717-724.CrossRefPubMed

83.

Guindon S, Gascuel O: A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Systematic Biology 2003, 52: 696-704. 10.1080/10635150390235520CrossRefPubMed

84.

Barry G, Hall E: Phylogenetic Trees Made Easy: A How-To Manual. Third edition. University of Rochester: Sinauer Associates, Inc.; 2007.

85.

Yang Z: PAML: a program package for phylogenetic analysis by maximum likelihood. Computer Applications in the Biosciences 1997, 13: 555-556.PubMed

86.

Llopart A, Comeron JM: Recurrent events of positive selection in independent Drosophila lineages at the spermatogenesis gene roughex. Genetics 2008, 179: 1009-1020. 10.1534/genetics.107.086231PubMedCentralCrossRefPubMed

Title: Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis
Authors: Yuki Furuse
Akira Suzuki
Taro Kamigaki
Hitoshi Oshitani
Publication date: 01-12-2009
Publisher: BioMed Central
Published in: Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/1743-422X-6-67

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis

Abstract

Background

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2009

Interaction of influenza virus NS1 protein with growth arrest-specific protein 8

Detection and quantification of pestivirus in experimentally infected pregnant ewes and their progeny

Nuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assays

A geminiviral amplicon (VA) derived from Tomato leaf curl virus (ToLCV) can replicate in a wide variety of plant species and also acts as a VIGS vector

From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge?

Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page